Search

everythinglearnresearchcommunity

for

Search:↓

The reply suggests checking for false positive or asymptomatic syphilis and using penicillin for treatment if necessary.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

People with androgenetic alopecia may have a higher risk of heart problems compared to those with alopecia areata or healthy individuals.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

The photolyase-based device significantly changed the size and heat of potential skin cancer areas in patients.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

A woman with ectopic Cushing's syndrome and COVID-19 passed away despite treatment.

Photobiomodulation therapy may help treat hair loss in people with darker skin, but more research is needed.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

A woman with a rare form of multiple myeloma had a headache and a skull mass, which led to her diagnosis after tests and a biopsy.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Certain genetic markers may increase or decrease prostate cancer risk.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Soy isoflavones can protect lung tissue from radiation damage.

Erlotinib can cause hair loss as a side effect.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.